TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 47 filers reported holding TANGO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,262 | -45.5% | 4,116,949 | 0.0% | 1.07% | -46.4% |
| Q4 2022 | $29,848 | -99.8% | 4,116,949 | 0.0% | 2.00% | +91.7% |
| Q3 2022 | $14,903,000 | -27.0% | 4,116,949 | -8.7% | 1.04% | -32.5% |
| Q2 2022 | $20,421,000 | -45.0% | 4,507,843 | -8.0% | 1.54% | -45.8% |
| Q1 2022 | $37,136,000 | -30.1% | 4,899,185 | 0.0% | 2.85% | -9.8% |
| Q4 2021 | $53,149,000 | +8.9% | 4,899,185 | +25.6% | 3.16% | +59.4% |
| Q3 2021 | $48,814,000 | – | 3,899,185 | – | 1.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $218,038,359 | 82.15% |
| Nextech Invest Ltd. | 5,533,980 | $62,312,615 | 18.88% |
| Boxer Capital, LLC | 7,123,642 | $80,212,209 | 4.27% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $32,571,385 | 3.64% |
| EcoR1 Capital, LLC | 8,721,636 | $98,205,621 | 3.31% |
| Samsara BioCapital, LLC | 630,000 | $7,093,800 | 2.17% |
| Soleus Capital Management, L.P. | 1,929,019 | $21,720,754 | 2.00% |
| Casdin Capital, LLC | 1,307,349 | $14,720,750 | 1.63% |
| Southpoint Capital Advisors LP | 5,276,699 | $59,415,631 | 1.33% |
| Affinity Asset Advisors, LLC | 350,000 | $3,941,000 | 1.11% |